medigraphic.com
SPANISH

Revista Mexicana de Medicina Transfusional

ISSN 2007-6509 (Print)
Órgano oficial de la Asociación Mexicana de Medicina Transfusional A.C.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2025, Number S1

<< Back Next >>

Rev Mex Med Transfus 2025; 17 (S1)

Escrutinio de hepatitis E para donadores de sangre

Levi JE
Full text How to cite this article 10.35366/121316

DOI

DOI: 10.35366/121316
URL: https://dx.doi.org/10.35366/121316

Language: Spanish
References: 13
Page: s23-25
PDF size: 190.07 Kb.


Key words:

No keywords




REFERENCES

  1. Nimgaonkar I, Ding Q, Schwartz RE, Ploss A. Hepatitis E virus: advances and challenges. Nat Rev Gastroenterol Hepatol. 2018; 15 (2): 96-110.

  2. Kamar N, Izopet J, Pavio N, Aggarwal R, Labrique A, Wedemeyer H, Dalton HR. Hepatitis E virus infection. Nat Rev Dis Primers. 2017; 3: 17086.

  3. Li P, Liu J, Li Y, Su J, Ma Z, Bramer WM et al. The global epidemiology of hepatitis E virus infection: a systematic review and meta-analysis. Liver Int. 2020; 40 (7): 1516-1528.

  4. WHO. Hepatitis E facts sheet. [Last access August 12, 2025]. Available in: https://www.who.int/news-room/fact-sheets/detail/hepatitis-e

  5. Magri MC, Manchiero C, Dantas BP, Bernardo WM, Abdala E, Tengan FM. Prevalence of hepatitis E in Latin America and the Caribbean: a systematic review and meta-analysis. Public Health. 2025; 244: 105745.

  6. Viera-Segura O, Calderón-Flores A, Batún-Alfaro JA, Fierro NA. Tracing the history of hepatitis E virus infection in Mexico: from the enigmatic genotype 2 to the current disease situation. Viruses 2023; 15 (9): 1911.

  7. Letafati A, Taghiabadi Z, Roushanzamir M, Memarpour B, Seyedi S, Farahani AV et al. From discovery to treatment: tracing the path of hepatitis E virus. Virol J. 2024; 21 (1): 194.

  8. Kamar N, Selves J, Mansuy JM, Ouezzani L, Péron JM, Guitard J et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med. 2008; 358 (8): 811-817.

  9. Versluis J, Pas SD, Agteresch HJ, de Man RA, Maaskant J, Schipper ME et al. Hepatitis E virus: an underestimated opportunistic pathogen in recipients of allogeneic hematopoietic stem cell transplantation. Blood. 2013; 122 (6): 1079-1086.

  10. Singson S, Shastry S, Sudheesh N, Chawla K, Madiyal M, Kandasamy D et al. Assessment of Hepatitis E virus transmission risks: a comprehensive review of cases among blood transfusion recipients and blood donors. Infect Ecol Epidemiol. 2024; 14 (1): 2406834.

  11. Hewitt PE, Ijaz S, Brailsford SR, Brett R, Dicks S, Haywood B et al. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet. 2014; 384 (9956): 1766-1773.

  12. Tanaka A, Matsubayashi K, Odajima T, Sakata H, Iida J, Kai K et al. Universal nucleic acid donor screening revealed epidemiological features of hepatitis E and prevented transfusion-transmitted infection in Japan. Transfusion. 2024; 64 (2): 335-347.

  13. Laperche S, Maugard C, Lhomme S, Lecam S, Ricard C, Dupont I et al. Seven years (2015-2021) of blood donor screening for HEV-RNA in France: lessons and perspectives. Blood Transfus. 2023; 21 (2): 110-118.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Med Transfus. 2025;17